New Zealand's controversial medicines purchasing agency Pharmac has announced that it will fund MSD's KEYTRUDA (pembrolizumab) and Roche's TECENTRIQ (atezolizumab) for people with locally advanced and metastatic non-small cell lung cancer. …
The long wait is finally over for New Zealand's lung cancer patients
March 13, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
'He will be deeply missed by all who had the pleasure of getting to know him'
August 6, 2025 - - Latest News -
Gilead announces recipients of inaugural GLOWS grants for Indigenous-led HIV and hepatitis projects
August 6, 2025 - - Latest News -
Arrotex Pharmaceuticals welcomes strategic US investment in DBG Health
August 5, 2025 - - Latest News -
'We do what we say we will do', 'lead by example' and 'find a way'
August 5, 2025 - - Latest News -
Novo Nordisk says that without action Australia 'faces a sobering reality' on life expectancy
August 5, 2025 - - Latest News -
A rigged system in which delays are the intent, not the consequence
August 5, 2025 - - Latest News -
TGA halts the promotion of some Vitamin D medicines for bone strength
August 4, 2025 - - Latest News